These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31325329)

  • 1. Theranostic approaches in nuclear oncology: From bench to bed.
    Nock BA; Maina T
    J Labelled Comp Radiopharm; 2019 Aug; 62(10):612-614. PubMed ID: 31325329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nuclear medicine diagnostics, therapy and theranostics in the context of modern oncology].
    Schaefer N; Prior J
    Ther Umsch; 2019 Sep; 76(4):167-172. PubMed ID: 31498036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear medicine theranostics comes of age.
    Herrmann K; Kraus BJ; Hadaschik B; Kunikowska J; van Poppel H; N'Dow J; Sartor O; Oyen WJG
    Lancet Oncol; 2021 Nov; 22(11):1497-1498. PubMed ID: 34735807
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic imaging in oncology. Proceedings of a meeting. Naples, Italy, 28-30 April 1993.
    Nucl Med Biol; 1994 Jul; 21(5):681-792. PubMed ID: 9289312
    [No Abstract]   [Full Text] [Related]  

  • 5. Nuclear Medicine in Cancer Theranostics: Beyond the Target.
    Taïeb D; Hicks RJ; Pacak K
    J Nucl Med; 2016 Nov; 57(11):1659-1660. PubMed ID: 27445288
    [No Abstract]   [Full Text] [Related]  

  • 6. An introduction to the clinical practice of theranostics in oncology.
    Turner JH
    Br J Radiol; 2018 Nov; 91(1091):20180440. PubMed ID: 30179054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear imaging in cancer theranostics.
    Del Vecchio S; Zannetti A; Fonti R; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):152-63. PubMed ID: 17420716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moonshot Acceleration Factor: Medical Imaging.
    Sevick-Muraca EM; Frank RA; Giger ML; Mulshine JL
    Cancer Res; 2017 Nov; 77(21):5717-5720. PubMed ID: 28993413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Bench to Bedside-The Bad Berka Experience With First-in-Human Studies.
    Zhang J; Singh A; Kulkarni HR; Schuchardt C; Müller D; Wester HJ; Maina T; Rösch F; van der Meulen NP; Müller C; Mäcke H; Baum RP
    Semin Nucl Med; 2019 Sep; 49(5):422-437. PubMed ID: 31470935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncology.
    Larson SM
    J Nucl Med; 2010 Sep; 51(9):19N-25N. PubMed ID: 20810752
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies.
    van der Meel R; Gallagher WM; Oliveira S; O'Connor AE; Schiffelers RM; Byrne AT
    Drug Discov Today; 2010 Feb; 15(3-4):102-14. PubMed ID: 20035896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special issue: Nuclear oncology.
    J Nucl Med; 1996 Jun; 37(6):885-1063. PubMed ID: 8683304
    [No Abstract]   [Full Text] [Related]  

  • 13. 2013 SNMMI Highlights Lecture: oncology.
    Wahl RL
    J Nucl Med; 2013 Nov; 54(11):11N-22N. PubMed ID: 24187043
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging Preclinical and Clinical Applications of Theranostics for Nononcological Disorders.
    Assadi M; Jokar N; Yordanova A; Gholamrezanezhad A; Amini A; Abbasi F; Biersack HJ; Amini A; Nabipour I; Ahmadzadehfar H
    PET Clin; 2021 Jul; 16(3):429-440. PubMed ID: 34053586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiopeptide imaging and therapy in Europe.
    Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
    J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear medicine and oncology.
    Lind P; Gallowitsch HJ
    Wien Med Wochenschr; 2012 Oct; 162(19-20):405-6. PubMed ID: 23099624
    [No Abstract]   [Full Text] [Related]  

  • 17. Which radionuclides will nuclear oncology need tomorrow?
    Barbet J; Chatal JF; Gauché F; Martino J
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):627-30. PubMed ID: 16741760
    [No Abstract]   [Full Text] [Related]  

  • 18. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
    Eberlein U; Cremonesi M; Lassmann M
    J Nucl Med; 2017 Sep; 58(Suppl 2):97S-103S. PubMed ID: 28864620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear image-guided personalized treatment and prevention of cancers.
    Yang DJ; Kong F; Shen LH; Inoue T; Zakko S
    Curr Med Chem; 2012; 19(20):3253-4. PubMed ID: 22664240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.